Ranibizumab versus verteporfin for neovascular age-related macular degeneration

David M. Brown, Peter K. Kaiser, Mark Michels, Gisele Soubrane, Jeffrey S. Heier, Robert Y. Kim, Judy P. Sy, Susan Schneider

Research output: Contribution to journalArticlepeer-review

2968 Scopus citations

Fingerprint

Dive into the research topics of 'Ranibizumab versus verteporfin for neovascular age-related macular degeneration'. Together they form a unique fingerprint.

Medicine & Life Sciences